Shah Pratibha Jain, Dubey Kamta Prasad, Watti Chhatarapal, Lalwani Jaya
Department of Anaesthesiology and Critical Care, Pt. J.N.M. Medical College and Dr. BRAM Hospital, Raipur (C.G.), India.
Indian J Anaesth. 2010 Jul;54(4):296-301. doi: 10.4103/0019-5049.68371.
Modified electroconvulsive therapy (ECT) is a safe and most effective treatment modality for major depressive disorders with suicidal tendencies. For this, one must have an ideal intravenous anaesthetic agent for induction which provides rapid onset, short duration of action, attenuates adverse physiological effect of ECT, rapid recovery without adverse shortening of seizure duration and minimum rise in serum potassium. The studies in search of an ideal intravenous anaesthetic agent are limited. Aim is to compare the effect of iv thiopentone, propofol and midazolam on induction time and quality, haemodynamics, Seizure duration, recovery time and changes in serum potassium level. 90 patients of ASA I and II of either sex having major depressive illness were randomly allocated into three groups (n = 30) based on iv induction agent used. Group I, Group II and Group III patients were induced with iv thiopentone 5 mg/kg, propofol 2 mg/kg and midazolam 0.2 mg/kg, respectively. The induction time, quality of induction, haemodynamic changes, seizure duration, recovery time and change in serum potassium level were measured and analyzed by Z test. Induction was quicker in propofol group i.e., 41.03 ± 6.11 sec than in thiopentone (50.6 ± 6.32 sec) and midazolam group (77.30 ± 6.67 sec). Seizure duration was significantly shorter in midazolam group compared to propofol and thiopentone groups. Though significant rise in HR, SBP DBP was observed in all the three groups following ECT, but rise was significantly higher in thiopentone group compared to other two groups. Significantly, faster recovery was observed with propofol. Rise in serum potassium after ECT was not significant in any of the groups. Propofol is a safe and suitable intravenous anaesthetic agent for induction of anaesthesia for modified ECT.
改良电休克疗法(ECT)是治疗伴有自杀倾向的重度抑郁症的一种安全且最有效的治疗方式。为此,必须有一种理想的静脉麻醉诱导剂,它起效迅速、作用时间短、能减轻ECT的不良生理效应、能快速恢复且不会缩短癫痫发作时间,血清钾升高幅度最小。寻找理想静脉麻醉诱导剂的研究有限。目的是比较静脉注射硫喷妥钠、丙泊酚和咪达唑仑对诱导时间和质量、血流动力学、癫痫发作持续时间、恢复时间以及血清钾水平变化的影响。90例患有重度抑郁症的ASA I级和II级患者,根据所使用的静脉诱导剂随机分为三组(n = 30)。第一组、第二组和第三组患者分别用5mg/kg静脉注射硫喷妥钠、2mg/kg丙泊酚和0.2mg/kg咪达唑仑进行诱导。通过Z检验测量并分析诱导时间、诱导质量、血流动力学变化、癫痫发作持续时间、恢复时间和血清钾水平变化。丙泊酚组的诱导更快,即41.03±6.11秒,快于硫喷妥钠组(50.6±6.32秒)和咪达唑仑组(77.30±6.67秒)。与丙泊酚组和硫喷妥钠组相比,咪达唑仑组的癫痫发作持续时间明显更短。虽然在ECT后所有三组患者的心率、收缩压和舒张压均有显著升高,但硫喷妥钠组的升高幅度明显高于其他两组。值得注意的是,丙泊酚组恢复更快。ECT后任何一组患者血清钾升高均不显著。丙泊酚是用于改良ECT麻醉诱导的一种安全且合适的静脉麻醉剂。